{"id":"https://openalex.org/W2952946014","doi":"https://doi.org/10.1021/jm00081a014","title":"Synthesis, antiproliferative, and antiviral activity of certain 4-aminopyrrolo[2,3-d]pyridazine nucleosides: an entry into a novel series of adenosine analogs","display_name":"Synthesis, antiproliferative, and antiviral activity of certain 4-aminopyrrolo[2,3-d]pyridazine nucleosides: an entry into a novel series of adenosine analogs","publication_year":1992,"publication_date":"1992-02-01","ids":{"openalex":"https://openalex.org/W2952946014","doi":"https://doi.org/10.1021/jm00081a014","mag":"2952946014","pmid":"https://pubmed.ncbi.nlm.nih.gov/1310744"},"language":"en","primary_location":{"id":"doi:10.1021/jm00081a014","doi":"https://doi.org/10.1021/jm00081a014","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00081a014","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051066572","display_name":"Eric A. Meade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric A. Meade","raw_affiliation_strings":["Department of Medicinal Chemistry and Pharmaceutical Chemistry, College of Pharmacy, University of Michigan, Ann Arbor 48109-1065"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry and Pharmaceutical Chemistry, College of Pharmacy, University of Michigan, Ann Arbor 48109-1065","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064750495","display_name":"Linda L. Wotring","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda L. Wotring","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110073621","display_name":"John C. Drach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Drach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037842232","display_name":"Leroy B. Townsend","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leroy B. Townsend","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.9543,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.73162098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"35","issue":"3","first_page":"526","last_page":"533"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.2551000118255615,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.2551000118255615,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.15230000019073486,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.12309999763965607,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-analogues","display_name":"adenosine analogues","score":0.8730000257492065},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8690000176429749},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.9940000176429749},{"id":"https://openalex.org/keywords/human-cytomegalovirus","display_name":"human cytomegalovirus","score":0.8309999704360962},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-1","display_name":"herpes simplex virus type 1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.8180000185966492},{"id":"https://openalex.org/keywords/hela-cells","display_name":"HeLa cells","score":0.5130000114440918},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9224908947944641},{"id":"https://openalex.org/C2777355660","wikidata":"https://www.wikidata.org/wiki/Q420238","display_name":"Pyridazine","level":2,"score":0.868809163570404},{"id":"https://openalex.org/C2780814088","wikidata":"https://www.wikidata.org/wiki/Q415872","display_name":"Boron trichloride","level":3,"score":0.7165094614028931},{"id":"https://openalex.org/C2779400197","wikidata":"https://www.wikidata.org/wiki/Q242627","display_name":"Pyrrole","level":2,"score":0.6049581170082092},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5967108607292175},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.49332061409950256},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.450104683637619},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.41412973403930664},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.17868950963020325},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.16454699635505676},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13741937279701233},{"id":"https://openalex.org/C501308230","wikidata":"https://www.wikidata.org/wiki/Q618","display_name":"Boron","level":2,"score":0.11309635639190674}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018139","descriptor_name":"Simplexvirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00081a014","doi":"https://doi.org/10.1021/jm00081a014","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00081a014","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:1310744","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1310744","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1354493293","display_name":"ANIMAL MODELS FOR ANTIVIRAL EVALUATION","funder_award_id":"n01ai062518-010","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G168524383","display_name":null,"funder_award_id":"N01-AI 42554","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2304742671","display_name":null,"funder_award_id":"N01-AI-62518","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3608580336","display_name":null,"funder_award_id":"N01 AI72641","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4273480390","display_name":"DRUGS TO TREAT HUMAN CYTOMEGALOVIRUS INFECTIONS","funder_award_id":"n01ai072641-011","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6077714088","display_name":"DEVELOP ANTIVIRAL DRUGS FOR CMV INFECTIONS IN AIDS","funder_award_id":"n01ai042554-001","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979765161","https://openalex.org/W7097063027","https://openalex.org/W2053651371","https://openalex.org/W2162315249","https://openalex.org/W2951809358","https://openalex.org/W2952855503","https://openalex.org/W2047694975","https://openalex.org/W2949874283","https://openalex.org/W2006271257","https://openalex.org/W2050841293"],"abstract_inverted_index":{"The":[0,84],"preparation":[1,18],"of":[2,22,33,60,68,107],"novel":[3],"heterocyclic":[4],"base":[5],"modified":[6],"adenosine":[7],"analogues,":[8],"the":[9,20,23,69,101,129],"4-aminopyrrolo[2,3-d]pyridazine":[10],"nucleosides,":[11],"is":[12],"described.":[13],"Crucial":[14],"to":[15],"their":[16],"successful":[17],"was":[19,55,116,132],"use":[21],"pyrrole":[24],"glycoside":[25],"intermediates":[26],"3-cyano-2-formyl-1-(2,3,5-tri-O-benzyl-beta-D-ribofuranosyl)pyrrole":[27],"(11)":[28],"and":[29,35,49,65,81,88,109,122],"3-cyano-2-formyl-1-(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)pyrrole":[30],"(17).":[31],"Treatment":[32],"11":[34],"17":[36],"with":[37,43,72],"hydrazine":[38],"dihydrochloride":[39],"followed":[40],"by":[41,57],"treatment":[42],"boron":[44,73],"trichloride":[45],"provided":[46],"4-amino-1-beta-D-ribofuranosylpyrrolo[2,3-d]pyridazine":[47],"(2)":[48,87],"4-amino-1-beta-D-arabinofuranosylpyrrolo[2,3-d]pyridazine":[50],"(3),":[51],"respectively.":[52],"4-Amino-3-bromo-1-beta-D-ribofuranosylpyrrolo[2,3-d]-pyridazine":[53],"(4)":[54],"prepared":[56],"a":[58],"bromination":[59],"4-amino-1-(2,3,5-tri-O-benzyl-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyri":[61],"daz":[62],"ine":[63],"(12)":[64],"subsequent":[66],"removal":[67],"benzyl":[70],"groups":[71],"trichloride.":[74],"Compounds":[75],"2-4":[76],"were":[77,93],"evaluated":[78],"for":[79],"antiproliferative":[80],"antiviral":[82,130],"activity.":[83],"tubercidin":[85],"analogue":[86,103],"its":[89],"arabinosyl":[90],"derivative":[91],"(3)":[92],"virtually":[94],"inactive":[95],"in":[96],"all":[97],"assays.":[98],"In":[99],"contrast,":[100],"3-bromo":[102],"4":[104,115],"inhibited":[105],"growth":[106],"L1210":[108],"H.":[110],"Ep.":[111],"2":[112],"cells.":[113],"Compound":[114],"also":[117],"active":[118],"against":[119],"human":[120],"cytomegalovirus":[121],"herpes":[123],"simplex":[124],"virus":[125],"type":[126],"1,":[127],"but":[128],"activity":[131],"not":[133],"completely":[134],"separated":[135],"from":[136],"cytotoxicity.":[137]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-27T00:00:00"}
